0000899243-22-027461.txt : 20220802
0000899243-22-027461.hdr.sgml : 20220802
20220802184004
ACCESSION NUMBER: 0000899243-22-027461
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220801
FILED AS OF DATE: 20220802
DATE AS OF CHANGE: 20220802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Louie Ngar Yee
CENTRAL INDEX KEY: 0001913264
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41455
FILM NUMBER: 221130431
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAIA Biotechnology, Inc.
CENTRAL INDEX KEY: 0001878313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
BUSINESS PHONE: 312-416-8592
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-01
0
0001878313
MAIA Biotechnology, Inc.
MAIA
0001913264
Louie Ngar Yee
444 WEST LAKE STREET,
SUITE 1700
CHICAGO
IL
60606
1
0
0
0
Common Stock
2022-08-01
4
P
0
20000
5.00
A
928584
D
These shares were purchased by the reporting person in the issuer's initial public offering, which closed on August 1, 2022.
/s/ Louie Ngar Yee
2022-08-02